PMID: 11920581Mar 29, 2002Paper

Cancer chemoresistance: the relationship between p53 and multidrug transporters

International Journal of Cancer. Journal International Du Cancer
Jason A Bush, Gang Li

Abstract

Extensive studies indicate that both p53 and multidrug transporters play important roles in chemoresistance. Since the initial reports a decade ago demonstrating a transcriptional dependence of the ABCB1 gene (MDR) promoter by p53, much data have been accumulated. However, despite being the subject of intense study, this p53-MDR relationship remains unclear in human cancers. The data are confounded by variable and contrasting results when considering the in vitro regulation and attempting to draw parallels in tissue specimens. The original model suggested that wild-type p53 downregulates the ABCB1 promoter, whereas mutant p53 increases expression of ABCB1. This review summarizes the data for and against this hypothesis. What emerges from these studies is a complex picture, where data have been obtained in support of this hypothesis, but there are also many circumstances where it is not supported. Taken together, these data suggest that the relationship between p53 and multidrug transporters is conditional. It is dependent on cellular environment, the drug used, and the nature of the p53 mutation.

References

Nov 11, 1976·Biochimica Et Biophysica Acta·R L Juliano, V Ling
Apr 1, 1992·Nature Genetics·W S el-DeiryB Vogelstein
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·I B RoninsonI Pastan
Jun 1, 1995·Nature Medicine·G L SchefferR J Scheper
Jan 27, 1995·The Journal of Biological Chemistry·M E GoldsmithK H Cowan
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·U SteinV Wunderlich
Mar 14, 1995·Biochimica Et Biophysica Acta·J J SmitP Borst
Apr 1, 1994·Leukemia & Lymphoma·J WallnerR Pirker
May 1, 1993·Nature Genetics·D DittmerA J Levine
Jul 1, 1993·Genes & Development·X WuA J Levine
Dec 26, 1995·Biochemical and Biophysical Research Communications·B E StraussM Haas
Jun 1, 1996·Journal of Clinical Pathology·Y SoiniP Pääkkö
Jan 1, 1996·Journal of Cancer Research and Clinical Oncology·E de KantC F Rochlitz
May 29, 1997·International Journal of Cancer. Journal International Du Cancer·S C LinnG Giaccone
Oct 6, 1997·Proceedings of the National Academy of Sciences of the United States of America·J V ThottasseryJ D Schuetz
Feb 14, 1998·Nature Medicine·B JansenH Pehamberger
Jun 23, 1998·The Journal of Biological Chemistry·G Zhou, M T Kuo
Dec 8, 1998·The Journal of Experimental Medicine·M MüllerP H Krammer
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·L A DoyleD D Ross
Feb 13, 1999·International Journal of Cancer. Journal International Du Cancer·R RalhanN K Shukla
Mar 5, 1999·Journal of Molecular Biology·P Chène, E Bechter
Oct 26, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Y FukushimaM Nakamura
Nov 26, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T TanakaM Kuwano
Feb 26, 2000·The Journal of Investigative Dermatology·G LiV C Ho
Apr 25, 2000·Biochemical and Biophysical Research Communications·T TakadaY Sugiyama
May 3, 2000·The Journal of Clinical Investigation·G F SullivanW N Hait
Jun 6, 2000·Mutation Research·G P Pfeifer

❮ Previous
Next ❯

Citations

May 3, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ting ZhouFeng Xu
Mar 31, 2004·Experimental Cell Research·Bent HonoréMogens H Claësson
Feb 27, 2004·Pediatric Neurology·Alberto LazarowskiAna Lía Taratuto
Aug 21, 2009·Nature Reviews. Cancer·Ran Brosh, Varda Rotter
Mar 14, 2009·Proceedings of the National Academy of Sciences of the United States of America·Long GuSusan E Kane
Jun 21, 2012·Genes & Development·William A Freed-Pastor, Carol Prives
Jul 24, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kari J Brewer SavannahDina Lev
Nov 7, 2002·Biological & Pharmaceutical Bulletin·Toshiyuki SakaedaKatsuhiko Okumura
Oct 30, 2009·International Journal of Molecular Sciences·Kyung Taek OhEun Seong Lee
Jan 30, 2013·World Journal of Surgical Oncology·Hai-Bin ZhuLi-Ping Xie
Apr 2, 2013·FEBS Letters·Peter Andorfer, Hans Rotheneder
Jul 23, 2009·Journal of Pharmaceutical Sciences·Kati-Sisko VellonenArto Urtti
Mar 27, 2012·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Jui-Chuan ChuangMing-Fang Wu
Sep 8, 2004·Cytometry. Part B, Clinical Cytometry·Geraldo Barroso CavalcantiRaquel C Maia
Mar 4, 2010·Cytometry. Part B, Clinical Cytometry·Geraldo Barroso CavalcantiRaquel Ciuvalschi Maia
Nov 23, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Emmanuel A HoMicheline Piquette-Miller
Jan 3, 2006·Cancer Letters·Khadidja HaïdaraGerald Batist
Dec 3, 2014·Cancer Letters·Anna L GreenshieldsDavid W Hoskin
Jan 18, 2006·Drug Metabolism and Pharmacokinetics·Toshiyuki Sakaeda
Sep 11, 2012·Biochemical and Biophysical Research Communications·Kimberly M SuttonDavid W Hoskin
Nov 12, 2016·Cold Spring Harbor Perspectives in Medicine·Neil T Pfister, Carol Prives
Nov 8, 2018·Endocrine-related Cancer·Mona AlharbiCarlos Salomon
Jan 16, 2020·International Journal of Molecular Sciences·Teodora CosteaMaria-Magdalena Mocanu
Jan 8, 2005·Clinical Chemistry·Michael J Duffy
Dec 13, 2019·Oxidative Medicine and Cellular Longevity·Tiziana Tataranni, Claudia Piccoli
Jan 16, 2016·Molecular Biology Reports·Amir MehdizadehMortaza Jabbarpour-Bonyadi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.